F. Moriconi

1.4k total citations
26 papers, 1.1k citations indexed

About

F. Moriconi is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, F. Moriconi has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in F. Moriconi's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (7 papers). F. Moriconi is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (7 papers). F. Moriconi collaborates with scholars based in Italy, China and Germany. F. Moriconi's co-authors include Maurizia Rossana Brunetto, Ferruccio Bonino, D. Cavallone, P. Colombatto, P. Ciccorossi, Filippo Oliveri, B. Coco, B. Cherubini, V. Romagnoli and Anna Maria Maina and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

F. Moriconi

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Moriconi Italy 10 991 952 83 73 66 26 1.1k
Jinpeng Su Germany 7 646 0.7× 528 0.6× 91 1.1× 33 0.5× 73 1.1× 19 716
Sayuri Nitta Japan 15 408 0.4× 489 0.5× 170 2.0× 51 0.7× 104 1.6× 40 681
Miyako Murakawa Japan 12 330 0.3× 401 0.4× 146 1.8× 45 0.6× 85 1.3× 31 583
Ronda K. Sapp United States 7 405 0.4× 480 0.5× 82 1.0× 40 0.5× 37 0.6× 8 574
Maria Cristina Cavallo Italy 5 541 0.5× 428 0.4× 403 4.9× 154 2.1× 108 1.6× 6 830
Huijuan Zhou China 13 363 0.4× 360 0.4× 65 0.8× 20 0.3× 37 0.6× 30 535
Fukiko Mitsui Japan 11 418 0.4× 423 0.4× 80 1.0× 56 0.8× 45 0.7× 20 554
Rajesh Panigrahi India 18 520 0.5× 433 0.5× 39 0.5× 25 0.3× 42 0.6× 29 645
Suzanne E. Bassett United States 9 418 0.4× 511 0.5× 77 0.9× 14 0.2× 41 0.6× 9 676
Oliver E. Amin United Kingdom 7 300 0.3× 227 0.2× 318 3.8× 89 1.2× 62 0.9× 10 572

Countries citing papers authored by F. Moriconi

Since Specialization
Citations

This map shows the geographic impact of F. Moriconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Moriconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Moriconi more than expected).

Fields of papers citing papers by F. Moriconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Moriconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Moriconi. The network helps show where F. Moriconi may publish in the future.

Co-authorship network of co-authors of F. Moriconi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Moriconi. A scholar is included among the top collaborators of F. Moriconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Moriconi. F. Moriconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moriconi, F., et al.. (2023). Monitoring the Microbiomes of Agricultural and Food Waste Treating Biogas Plants over a One-Year Period. Applied Sciences. 13(17). 9959–9959. 4 indexed citations
2.
Colombatto, P., Cristiana Barbera, Flavia Bortolotti, et al.. (2018). HBV pre‐core mutant in genotype‐D infected children is selected during HBeAg/anti‐HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood. Journal of Medical Virology. 90(7). 1232–1239. 8 indexed citations
3.
Oliveri, Filippo, D. Cavallone, P. Colombatto, et al.. (2017). Long‐term outcome of inactive and active, low viraemic HBeAg‐negative‐hepatitis B virus infection: Benign course towards HBsAg clearance. Liver International. 37(11). 1622–1631. 49 indexed citations
4.
Yuan, Quan, Liuwei Song, D. Cavallone, et al.. (2015). Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease. PLoS ONE. 10(6). e0130209–e0130209. 45 indexed citations
5.
Qasim, Waseem, Maurizia Rossana Brunetto, Adam J. Gehring, et al.. (2014). Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. Journal of Hepatology. 62(2). 486–491. 165 indexed citations
6.
Brunetto, Maurizia Rossana, D. Cavallone, Filippo Oliveri, et al.. (2014). A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection. PLoS ONE. 9(10). e110782–e110782. 38 indexed citations
7.
8.
Cavallone, D., F. Moriconi, P. Colombatto, et al.. (2013). Optimization of in vitro HBV replication and HBsAg production in HuH7 cell line. Journal of Virological Methods. 189(1). 110–117. 4 indexed citations
9.
Moriconi, F., et al.. (2013). Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development. Zeitschrift für Gastroenterologie. 51(1). 1 indexed citations
10.
Coppola, Nicola, Gilda Tonziello, P. Colombatto, et al.. (2013). Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. Journal of Infection. 67(4). 322–328. 28 indexed citations
11.
Qasim, Waseem, Maurizia Rossana Brunetto, Adam J. Gehring, et al.. (2013). 251 THERAPY WITH T CELL RECEPTOR GENE MODIFIED T CELLS TARGETING HBsAg-PRODUCING HCC METASTASES. Journal of Hepatology. 58. S107–S107. 1 indexed citations
12.
Colombatto, P., F. Moriconi, Filippo Oliveri, et al.. (2013). T-06 Early HCV-Core-Ag kinetics predict sustained virologic response in chronic hepatitis C patients treated with standard of care. Digestive and Liver Disease. 45. S14–S15. 1 indexed citations
13.
Moriconi, F., D. Cavallone, P. Colombatto, et al.. (2012). P.03.1 IN-HOUSE ALLELE SPECIFIC PCR METHOD TO STUDY THE KINETICS OF RESISTANT VARIANTS DURING NUCLEOS(T)IDE ANALOGS TREATMENT IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS. Digestive and Liver Disease. 44. S99–S99. 1 indexed citations
14.
Brunetto, Maurizia Rossana, Filippo Oliveri, P. Colombatto, et al.. (2010). Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers. Gastroenterology. 139(2). 483–490. 305 indexed citations
15.
16.
Brunetto, Maurizia Rossana, F. Moriconi, Ferruccio Bonino, et al.. (2008). Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †. Hepatology. 49(4). 1141–1150. 369 indexed citations
17.
Ciccorossi, P., Anna Maria Maina, Filippo Oliveri, et al.. (2007). Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C. Liver International. 27(5). 612–619. 22 indexed citations
18.
Moriconi, F., P. Colombatto, B. Coco, et al.. (2007). Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. Journal of Antimicrobial Chemotherapy. 60(2). 341–349. 17 indexed citations
19.
Moriconi, F., Michael R. Beard, & Lilly Yuen. (2005). Bioinformatics Methods for the Analysis of Hepatitis Viruses. Antiviral Therapy. 18(3_part_2). 531–539. 3 indexed citations
20.
Moriconi, F., et al.. (1980). Total zinc and protein-bound fractions in normal dogs and dogs with fractures.. 31. 81–85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026